Rosuvastatin is used for: Hyperlipidaemias; Primary hypercholesterolaemia (heterozygous familial hypercholesterolaemia); mixed dyslipidaemia; homozygous familial hypercholesterolaemia; Stroke prevention.
Recorded in the NepalDoc medicine catalog for Rosuvastatin.
Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease based on age, high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, and at least one additional CV risk factor.
From the U.S. FDA-approved label for Rosuvastatin. Full label: DailyMed.
Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease based on age, high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, and at least one additional CV risk factor. As an adjunct to diet to: Reduce low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. Reduce LDL-C and slow the progression of atherosclerosis in adults. Reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia.
From the U.S. FDA-approved label for Rosuvastatin. Full label: DailyMed.
Take orally with or without food, at any time of day. Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating rosuvastatin tablets, and adjust dosage if necessary. Adults: Recommended dosage range is 5 to 40 mg once daily.
Directions from the U.S. FDA-approved label for Rosuvastatin — your doctor or pharmacist may advise differently.
Rosuvastatin tablets is contraindicated in the following conditions: Acute liver failure or decompensated cirrhosis. Hypersensitivity to rosuvastatin or any excipients in rosuvastatin tablets. Hypersensitivity reactions including rash, pruritus, urticaria, and angioedema have been reported with rosuvastatin. Acute liver failure or decompensated cirrhosis. Hypersensitivity to rosuvastatin or any excipients in rosuvastatin tablets.
Excerpt from the U.S. FDA-approved label for Rosuvastatin. Talk to a pharmacist or doctor before use.
Myopathy and Rhabdomyolysis: Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher rosuvastatin dosage. Asian patients may be at higher risk for myopathy. Discontinue rosuvastatin if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue rosuvastatin in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis. Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing rosuvastatin dosage.
Warnings and precautions excerpt from the U.S. FDA-approved label for Rosuvastatin — not a complete list. Talk to a pharmacist or doctor before use.
The following important adverse reactions are described below and elsewhere in the labeling: Myopathy and Rhabdomyolysis Immune-Mediated Necrotizing Myopathy Hepatic Dysfunction Proteinuria and Hematuria Increases in HbA1c and Fasting Serum Glucose Levels Most frequent adverse reactions (rate ≥2%) are headache, nausea, myalgia, asthenia, and constipation.
Excerpt from the U.S. FDA-approved label for Rosuvastatin — not a complete list. Talk to a pharmacist or doctor about side effects.
73 brands · 26 makers in the NepalDoc catalog — see the full Rosuvastatin guide →
Storage Store at controlled room temperature, 20ºC to 25ºC (68ºF to 77ºF); Protect from moisture.
Storage information from the U.S. FDA-approved label for Rosuvastatin.
What is Rovalip?
Rovalip 10mg Tablet is a Rosuvastatin medicine made by Omnica Laboratories Pvt. Ltd.. It comes as 10mg Tablet.
What is Rovalip used for?
Rosuvastatin is used for Hyperlipidaemias, Primary hypercholesterolaemia (heterozygous familial hypercholesterolaemia), mixed dyslipidaemia, homozygous familial hypercholesterolaemia, Stroke prevention.
What is the generic name of Rovalip?
The generic name of Rovalip is Rosuvastatin.
Which brands of Rosuvastatin are available in Nepal?
73 brands of Rosuvastatin are listed in the NepalDoc catalog, from 26 makers — including Arvast 40mg Tablet, Arvast 10mg Tablet, Arvast 20mg Tablet, Arvast 5mg Tablet, Crestor 5mg Tablet, Crestor 20mg Tablet.
What are the side effects of Rosuvastatin?
The following important adverse reactions are described below and elsewhere in the labeling: Myopathy and Rhabdomyolysis Immune-Mediated Necrotizing Myopathy Hepatic Dysfunction Proteinuria and Hematuria Increases in HbA1c and Fasting Serum Glucose Levels Most frequent adverse reactions (rate ≥2%) are headache, nausea, myalgia, asthenia, and constipation.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
